Elevate Campuses IPO GMP Today, Price & Details
Elevate Campuses IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Elevate Campuses
Elevate Campuses is set to launch its Initial Public Offering (IPO) on the NSE's Main Board, aiming to raise capital through a substantial fresh issue. The company operates within the education sector, likely focusing on campus-related services or infrastructure, although specific details of its business model aren't provided in the data. The IPO aims to tap into public markets to fund its expansion and growth initiatives. The issue size is significant at ₹2550 Cr, entirely comprising a fresh issue, which means the entire proceeds will go towards the company's development and operational needs, rather than being used by existing shareholders to exit.
The financial snapshot provided reveals an interesting picture. Elevate Campuses reported revenues of ₹559.16 Cr and a Profit After Tax (PAT) of ₹90.34 Cr. This suggests a healthy profitability margin. The Earnings Per Share (EPS) is reported at a very high ₹8211, which, when juxtaposed with the P/E ratio of 0.04x, indicates a potentially very attractive valuation if these numbers are accurate and sustainable. The company also boasts a strong EBITDA margin of 68.93%, pointing towards operational efficiency and robust cost management.
With a Net Asset Value (NAV) of ₹317.9 per share and a Return on Net Worth (RONW) of 6.74%, the company's financial health appears solid. The entire ₹2550 Cr raised will be a fresh issue, signalling an intention to inject capital directly into the business for future projects or working capital. This IPO structure is generally viewed positively by investors as it directly contributes to the company's growth potential. The lead managers for this offering are JM Financial Ltd., IIFL Capital Services Ltd., and Morgan Stanley India Co. Pvt. Ltd., with Kfin Technologies Ltd. acting as the registrar.
Elevate Campuses IPO — Investment Analysis
The valuation of Elevate Campuses' IPO presents a peculiar situation, primarily due to its reported P/E ratio of 0.04x against an EPS of ₹8211. Typically, a P/E of 0.04x would suggest an extremely undervalued stock, especially with such a high EPS. However, it's crucial to scrutinize the basis of this EPS calculation and whether it reflects normalized earnings. The price band of ₹343 to ₹362 per share, when considered with the reported NAV of ₹317.9, suggests the IPO is priced at a slight premium to its book value. The low P/E could imply that the market is either pricing in significant future growth or there are underlying factors not fully captured in the provided data that warrant caution. Investors will need to understand the methodology behind the reported EPS to truly gauge the IPO's valuation attractiveness.
Financially, Elevate Campuses seems to be on a strong footing, at least based on the provided metrics. A revenue of ₹559.16 Cr coupled with a PAT of ₹90.34 Cr translates to a net profit margin of approximately 16.16%. This is further bolstered by an exceptionally high EBITDA margin of 68.93%, which points to excellent operational efficiency and strong pricing power or cost control. The Return on Net Worth (RONW) at 6.74% is moderate, suggesting room for improvement in shareholder returns. While the provided data doesn't include a revenue trajectory over multiple years, the current profitability figures are encouraging, indicating a well-managed business.
The IPO structure, being a 100% fresh issue of ₹2550 Cr, is a significant positive, as all funds raised will be directly infused into the company for its growth and expansion plans. This avoids the dilution concerns often associated with Offer for Sale (OFS) components. However, the absence of detailed historical financial data, such as year-on-year revenue growth, debt levels, and a comprehensive breakdown of expenses, limits a full understanding of the company's long-term growth outlook and potential sector-specific risks. Any specific risks related to the education sector's regulatory environment or competitive landscape would need further investigation.
The subscription levels offer a mixed signal regarding market sentiment. With a total subscription of 2.66x, the IPO has seen oversubscription. Notably, the Qualified Institutional Buyers (QIBs) portion is subscribed at 2.66x, which is generally a positive indicator as institutional investors conduct thorough due diligence. However, the Retail and High Net-worth Individual (HNI) categories are subscribed at 1.07x and 0.89x respectively, which are relatively subdued. This suggests that while institutional interest is present, the broader market, especially retail investors, might be exercising more caution, possibly due to the unusual valuation metrics or a lack of clarity on the business model. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Elevate Campuses IPO — Pros & Cons
Strengths
- The company boasts an exceptionally high EBITDA margin of 68.93%, indicating strong operational efficiency and cost control. This suggests that Elevate Campuses is highly effective at converting its revenue into operational profit, which is a positive sign for its business model.
- The IPO is structured as a 100% fresh issue of ₹2550 Cr, meaning all the capital raised will be used to fund the company's growth and expansion. This directly benefits the company's future prospects and avoids the dilution concerns associated with an Offer for Sale (OFS).
- The reported Net Profit After Tax (PAT) of ₹90.34 Cr on revenues of ₹559.16 Cr suggests a healthy net profit margin of over 16%. This indicates strong profitability and the company's ability to generate significant earnings from its operations.
- The Net Asset Value (NAV) stands at ₹317.9 per share, and the IPO price band of ₹343 to ₹362 is priced at a slight premium to this NAV. This suggests that the market is valuing the company's future growth prospects and earning potential, which can be a positive indicator for investors looking for growth.
- The Qualified Institutional Buyers (QIBs) portion of the IPO has been subscribed 2.66x. This indicates a degree of confidence from institutional investors who typically conduct thorough due diligence, suggesting they see fundamental value in the company.
Risks
- The P/E ratio of 0.04x, when combined with an EPS of ₹8211, appears unusually low and warrants deeper investigation. This discrepancy could suggest potential accounting nuances or a need to understand the sustainability of such high EPS, raising concerns about the reliability of the reported valuation metrics.
- The Return on Net Worth (RONW) of 6.74% is relatively modest, especially when compared to the high EBITDA margins. This suggests that while the company is operationally efficient, it might not be generating optimal returns for its shareholders, which could be a point of concern for value-conscious investors.
- The subscription levels for the Retail (1.07x) and Non-Institutional Investor (NII) (0.89x) categories are relatively subdued. This indicates a lack of strong demand from individual and high-net-worth investors, who might be exercising caution due to the unusual valuation or lack of clarity on business specifics.
- The provided data lacks a historical financial track record, such as year-on-year revenue growth, profit trends, or debt levels. Without this context, it's challenging to assess the company's growth trajectory and its ability to sustain current performance, making it difficult for investors to make informed long-term decisions.
- The exact nature of Elevate Campuses' business operations is not detailed in the provided data. Operating in the education sector can involve specific regulatory risks, competitive pressures, and evolving market dynamics that are not quantifiable with the current information, making it hard to assess sector-specific risks.
Elevate Campuses IPO Details
| Company Name | Elevate Campuses |
|---|---|
| IPO Type | MAINBOARD |
| Exchange | NSE |
| Price Band | ₹343 - ₹362 |
| Face Value | ₹1 per share |
| Lot Size | 41 shares |
| Min Investment | ₹14,842 |
| Total Issue Size | ₹2,550.00 Cr |
|---|---|
| Fresh Issue | ₹2,550.00 Cr |
| Registrar | Kfin Technologies Ltd. |
| Lead Manager | JM Financial Ltd., IIFL Capital Services Ltd., Morgan Stanley India Co.Pvt.Ltd. |
| IPO Status | Listed |
Elevate Campuses IPO Dates
Elevate Campuses IPO Subscription Status
Elevate Campuses IPO Listing Performance
Elevate Campuses IPO listed on NSE on 30 Sep 2026 at ₹357, a discount of 1.5% below the issue price of ₹362. Investors who received allotment faced a loss of ₹226 per lot (41 shares) on listing day.
Elevate Campuses IPO — Key Highlights
- Elevate Campuses is launching a substantial IPO with a total issue size of ₹2550 Cr, entirely through a fresh issue.
- The company reports a remarkable EBITDA margin of 68.93%, indicating strong operational efficiency.
- A Net Profit After Tax (PAT) of ₹90.34 Cr on revenues of ₹559.16 Cr points to a healthy profitability.
- The IPO price band is set between ₹343 to ₹362 per share.
- Qualified Institutional Buyers (QIBs) have shown interest, with their portion subscribed at 2.66x.
Elevate Campuses Financial Performance
| Metric (₹ Cr) | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Revenue | 434.58 | 521.22 | 559.16 |
| Expenses | 380.78 | 441.33 | 443.82 |
| Net Income (PAT) | 37.29 | 19.60 | 90.34 |
| Margin (%) | 8.58% | 3.76% | 16.16% |
Elevate Campuses IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹8,211.00 |
|---|---|
| P/E Ratio | 0.04x |
| NAV | ₹317.90 |
| Debt/Equity | 1.720 |
Return Metrics
| RONW (%) | 6.74% |
|---|---|
| EBITDA Margin | 68.93% |
Elevate Campuses IPO Reservation / Allocation
Elevate Campuses IPO Anchor Investors
| Bid Date | Coming soon |
|---|---|
| Shares Offered | Coming soon |
| Anchor Portion (INR Cr.) | Coming soon |
| Anchor lock-in period end date for 50% shares (30 Days) | Coming soon |
| Anchor lock-in period end date for remaining shares (90 Days) | Coming soon |
Elevate Campuses IPO Lead Manager & Registrar
Book Running Lead Manager
JM Financial Ltd., IIFL Capital Services Ltd., Morgan Stanley India Co.Pvt.Ltd.
IPO Registrar
Kfin Technologies Ltd.
Elevate Campuses IPO — Frequently Asked Questions
What is Elevate Campuses IPO GMP today?
As of today, the Grey Market Premium (GMP) for Elevate Campuses IPO is not available at this time. GMP values are updated daily based on grey market activity.
What is the price band and lot size of Elevate Campuses IPO?
Elevate Campuses IPO has a price band of ₹343 to ₹362 per equity share with a face value of ₹1. The minimum lot size is 41 shares, requiring a minimum investment of ₹14,842 at the upper band.
What are the important dates for Elevate Campuses IPO?
Elevate Campuses IPO opens for subscription on TBA and closes on TBA. The shares are expected to list on NSE on 30 Sep 2026.
What is the investor category allocation in Elevate Campuses IPO?
The shares are reserved as follows — Qualified Institutional Buyers (QIB): 0.00%, Non-Institutional Investors (NII/HNI): 0.00%, and Retail Individual Investors: 10.00%.
How can I apply for Elevate Campuses IPO?
You can apply for Elevate Campuses IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is Kfin Technologies Ltd..
What is the subscription status of Elevate Campuses IPO?
Elevate Campuses IPO has been subscribed 2.66 times overall. Retail category: 1.07x, NII/HNI: 0.89x, QIB: 2.66x.
What is Elevate Campuses IPO price band and lot size?
The Elevate Campuses IPO is offering shares in a price band of ₹343 to ₹362 per share. The lot size for this IPO is 41 shares, meaning the minimum investment amount for retail investors will be ₹14,842 (41 shares * ₹362). The face value of each share is ₹1.
Is Elevate Campuses IPO worth investing in?
The IPO presents a mixed bag. On one hand, it shows strong operational efficiency with an impressive EBITDA margin of 68.93% and a healthy net profit margin. However, the unusual P/E ratio of 0.04x and a moderate RONW of 6.74% raise questions about valuation and shareholder returns.
The 100% fresh issue of ₹2550 Cr is a positive for growth, but the lack of historical financial data and business specifics makes a comprehensive assessment challenging. Investors should carefully weigh the attractive margins against the valuation anomalies and subdued retail subscription. Investors should consult a SEBI-registered financial advisor.
What is Elevate Campuses IPO GMP today?
Grey Market Premium (GMP) is an unofficial indicator of demand for an IPO. While specific GMP figures for Elevate Campuses are not provided in the data, a positive GMP generally suggests strong demand and potential listing gains. However, GMP is highly volatile and not a reliable factor for investment decisions.
Investors should not rely solely on GMP for their investment choices.
How to apply for Elevate Campuses IPO?
You can apply for the Elevate Campuses IPO through your demat account via online banking platforms or through your stockbroker. Applications can be submitted using the UPI mechanism or the ASBA (Application Supported by Blocked Amount) facility. Your application will be processed by the registrar, Kfin Technologies Ltd., and funds will be blocked until the allotment process is completed.